US Patent

US9161914 — Topical compositions and methods for making and using same

Method of Use · Assigned to Merz Pharmaceuticals LLC · Expires 2033-01-31 · 7y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects improved topical gel compositions containing an active agent and methods for making and using them.

USPTO Abstract

The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.

Drugs covered by this patent

naftifine-hydrochloride (NAFTIFINE HYDROCHLORIDE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-540`	—	naftifine-hydrochloride

Patent Metadata

Patent number: US9161914
Jurisdiction: US
Classification: Method of Use
Expires: 2033-01-31
Drug substance claim: No
Drug product claim: No
Assignee: Merz Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.